You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Talazoparib

Showing 101 - 107 of 107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Disease Progression Trial in Worldwide (De novo tumor tissue biopsy, Research blood draws)

Terminated
  • Disease Progression
  • De novo tumor tissue biopsy
  • Research blood draws
  • Daphne, Alabama
  • +32 more
May 12, 2021

Triple Negative Metastatic Breast Cancer, BRCA-mutated Solid Tumor Trial in San Francisco (BMN-673, Carboplatin, Paclitaxel)

Terminated
  • Triple Negative Metastatic Breast Cancer
  • BRCA-mutated Solid Tumor
  • San Francisco, California
    University of California San Francisco
Jan 7, 2020

Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,

Withdrawn
  • Estrogen Receptor Negative
  • +22 more
  • Laboratory Biomarker Analysis
  • +2 more
  • (no location specified)
Apr 20, 2017

Adult Solid Tumor, Estrogen Receptor Negative, Fallopian Tube Serous Tumor Trial (Hsp90 Inhibitor AT13387, Laboratory Biomarker

Withdrawn
  • Adult Solid Neoplasm
  • +12 more
  • Hsp90 Inhibitor AT13387
  • +3 more
  • (no location specified)
Jul 22, 2016

Human Volunteers Trial in Evansville (BMN 673)

Completed
  • Human Volunteers
  • BMN 673
  • Evansville, Indiana
    Covance Clinical Research Unit Inc.
Jul 26, 2017

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia Trial in United Kingdom, United States (BMN 673)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • BMN 673
  • Indianapolis, Indiana
  • +6 more
Sep 14, 2017

Solid Tumors, Carcinoma, Non-Small Cell Lung, NSCLC Trial (Cisplatin, Gemcitabine, Talazoparib)

Withdrawn
  • Solid Tumors
  • +4 more
  • (no location specified)
Feb 10, 2016